Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AKY7
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 2 |
GO:0003824 | catalytic activity | 1 | 2 |
GO:0004518 | nuclease activity | 4 | 2 |
GO:0005488 | binding | 1 | 2 |
GO:0016787 | hydrolase activity | 2 | 2 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 161 | 163 | PF00675 | 0.278 |
CLV_NRD_NRD_1 | 172 | 174 | PF00675 | 0.441 |
CLV_PCSK_KEX2_1 | 168 | 170 | PF00082 | 0.417 |
CLV_PCSK_KEX2_1 | 83 | 85 | PF00082 | 0.273 |
CLV_PCSK_PC1ET2_1 | 168 | 170 | PF00082 | 0.333 |
CLV_PCSK_PC1ET2_1 | 83 | 85 | PF00082 | 0.273 |
CLV_PCSK_SKI1_1 | 174 | 178 | PF00082 | 0.472 |
DEG_APCC_DBOX_1 | 56 | 64 | PF00400 | 0.366 |
DOC_CKS1_1 | 177 | 182 | PF01111 | 0.433 |
DOC_CKS1_1 | 94 | 99 | PF01111 | 0.350 |
DOC_CYCLIN_RxL_1 | 102 | 115 | PF00134 | 0.316 |
DOC_MAPK_gen_1 | 102 | 111 | PF00069 | 0.298 |
DOC_MAPK_gen_1 | 55 | 63 | PF00069 | 0.352 |
DOC_MAPK_HePTP_8 | 48 | 60 | PF00069 | 0.398 |
DOC_MAPK_MEF2A_6 | 104 | 113 | PF00069 | 0.273 |
DOC_MAPK_MEF2A_6 | 51 | 60 | PF00069 | 0.490 |
DOC_PP1_RVXF_1 | 179 | 186 | PF00149 | 0.348 |
DOC_PP4_FxxP_1 | 138 | 141 | PF00568 | 0.366 |
DOC_PP4_FxxP_1 | 177 | 180 | PF00568 | 0.349 |
DOC_USP7_MATH_1 | 13 | 17 | PF00917 | 0.708 |
DOC_USP7_MATH_1 | 155 | 159 | PF00917 | 0.183 |
DOC_USP7_UBL2_3 | 91 | 95 | PF12436 | 0.273 |
DOC_WW_Pin1_4 | 137 | 142 | PF00397 | 0.408 |
DOC_WW_Pin1_4 | 176 | 181 | PF00397 | 0.429 |
DOC_WW_Pin1_4 | 212 | 217 | PF00397 | 0.339 |
DOC_WW_Pin1_4 | 93 | 98 | PF00397 | 0.350 |
LIG_14-3-3_CanoR_1 | 107 | 112 | PF00244 | 0.345 |
LIG_14-3-3_CanoR_1 | 202 | 207 | PF00244 | 0.349 |
LIG_BIR_III_2 | 28 | 32 | PF00653 | 0.478 |
LIG_BRCT_BRCA1_1 | 109 | 113 | PF00533 | 0.393 |
LIG_Clathr_ClatBox_1 | 60 | 64 | PF01394 | 0.309 |
LIG_FHA_1 | 201 | 207 | PF00498 | 0.377 |
LIG_FHA_1 | 45 | 51 | PF00498 | 0.310 |
LIG_FHA_2 | 142 | 148 | PF00498 | 0.226 |
LIG_FHA_2 | 30 | 36 | PF00498 | 0.535 |
LIG_FHA_2 | 47 | 53 | PF00498 | 0.429 |
LIG_FHA_2 | 67 | 73 | PF00498 | 0.149 |
LIG_HCF-1_HBM_1 | 40 | 43 | PF13415 | 0.368 |
LIG_Integrin_isoDGR_2 | 171 | 173 | PF01839 | 0.262 |
LIG_LIR_Apic_2 | 137 | 141 | PF02991 | 0.366 |
LIG_LIR_Gen_1 | 103 | 113 | PF02991 | 0.345 |
LIG_NRP_CendR_1 | 221 | 224 | PF00754 | 0.351 |
LIG_SH2_NCK_1 | 139 | 143 | PF00017 | 0.273 |
LIG_SH2_STAP1 | 74 | 78 | PF00017 | 0.318 |
LIG_SH2_STAT5 | 81 | 84 | PF00017 | 0.274 |
LIG_SH3_3 | 111 | 117 | PF00018 | 0.274 |
LIG_SH3_3 | 216 | 222 | PF00018 | 0.339 |
LIG_SUMO_SIM_par_1 | 202 | 207 | PF11976 | 0.223 |
LIG_SUMO_SIM_par_1 | 46 | 52 | PF11976 | 0.338 |
LIG_WRC_WIRS_1 | 135 | 140 | PF05994 | 0.366 |
MOD_CDC14_SPxK_1 | 215 | 218 | PF00782 | 0.418 |
MOD_CDK_SPK_2 | 176 | 181 | PF00069 | 0.357 |
MOD_CDK_SPxK_1 | 212 | 218 | PF00069 | 0.420 |
MOD_CK1_1 | 115 | 121 | PF00069 | 0.366 |
MOD_CK2_1 | 29 | 35 | PF00069 | 0.560 |
MOD_CK2_1 | 46 | 52 | PF00069 | 0.398 |
MOD_CK2_1 | 66 | 72 | PF00069 | 0.249 |
MOD_Cter_Amidation | 171 | 174 | PF01082 | 0.366 |
MOD_GlcNHglycan | 117 | 120 | PF01048 | 0.329 |
MOD_GlcNHglycan | 15 | 18 | PF01048 | 0.589 |
MOD_GlcNHglycan | 157 | 160 | PF01048 | 0.466 |
MOD_GSK3_1 | 137 | 144 | PF00069 | 0.357 |
MOD_GSK3_1 | 185 | 192 | PF00069 | 0.426 |
MOD_GSK3_1 | 9 | 16 | PF00069 | 0.612 |
MOD_N-GLC_2 | 3 | 5 | PF02516 | 0.647 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.558 |
MOD_NEK2_2 | 134 | 139 | PF00069 | 0.366 |
MOD_NMyristoyl | 1 | 7 | PF02799 | 0.532 |
MOD_PK_1 | 202 | 208 | PF00069 | 0.227 |
MOD_Plk_1 | 35 | 41 | PF00069 | 0.469 |
MOD_Plk_2-3 | 35 | 41 | PF00069 | 0.335 |
MOD_Plk_2-3 | 46 | 52 | PF00069 | 0.359 |
MOD_Plk_4 | 107 | 113 | PF00069 | 0.390 |
MOD_Plk_4 | 134 | 140 | PF00069 | 0.340 |
MOD_ProDKin_1 | 137 | 143 | PF00069 | 0.408 |
MOD_ProDKin_1 | 176 | 182 | PF00069 | 0.427 |
MOD_ProDKin_1 | 212 | 218 | PF00069 | 0.347 |
MOD_ProDKin_1 | 93 | 99 | PF00069 | 0.350 |
TRG_ENDOCYTIC_2 | 105 | 108 | PF00928 | 0.335 |
TRG_ER_diArg_1 | 55 | 58 | PF00400 | 0.436 |
TRG_NLS_Bipartite_1 | 162 | 177 | PF00514 | 0.376 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P4K0 | Leptomonas seymouri | 55% | 100% |
A0A0S4IY10 | Bodo saltans | 30% | 92% |
A0A1X0NDZ2 | Trypanosomatidae | 44% | 100% |
A0A1X0NKT8 | Trypanosomatidae | 44% | 100% |
A0A3S7WPM0 | Leishmania donovani | 86% | 100% |
A4HT00 | Leishmania infantum | 85% | 100% |
E9AI24 | Leishmania braziliensis | 73% | 100% |
O32001 | Bacillus subtilis (strain 168) | 29% | 76% |
Q4QIW8 | Leishmania major | 85% | 100% |